Solubilization of epinephrine-specific alpha-adrenergic receptors from adrenocortical carcinoma.
D000306:Adrenal Cortex Neoplasms / Q000032:analysis*; D000818:Animals; D002793:Cholic Acids; D004088:Dihydroergotoxine / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism*; D011941:Receptors, Adrenergic / Q000302:isolation & purification*; D011942:Receptors, Adrenergic, alpha / Q000302:isolation & purification* / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000032:analysis; D018043:Receptors, Corticotropin; D012995:Solubility
D002793:Cholic Acids; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D011956:Receptors, Cell Surface; D018043:Receptors, Corticotropin; D004088:Dihydroergotoxine; C028213:3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate; D004837:Epinephrine